title: [Combined therapy of inoperable esophageal cancer].
authors.forename: U
authors.initials: U
authors.lastname: Fink
authors.forename: G
authors.initials: G
authors.lastname: Pfeiffer
authors.forename: A
authors.initials: A
authors.lastname: Gossmann
authors.forename: P
authors.initials: P
authors.lastname: Lukas
authors.forename: H J
authors.initials: HJ
authors.lastname: Wilke
authors.forename: P
authors.initials: P
authors.lastname: Preusser
authors.forename: J R
authors.initials: JR
authors.lastname: Siewert
mesh_terms: D000970:Antineoplastic Agents / Q000627:therapeutic use*; D000971:Antineoplastic Combined Chemotherapy Protocols / Q000627:therapeutic use*; D003131:Combined Modality Therapy; D004938:Esophageal Neoplasms / Q000188:drug therapy* / Q000473:pathology / Q000532:radiotherapy / Q000601:surgery; D005500:Follow-Up Studies; D006801:Humans; D009367:Neoplasm Staging
chemical_list: D000970:Antineoplastic Agents
vernacular_title: Kombinierte Therapie beim inoperablen Oesophaguscarcinom.